Itaconate and its derivatives as anti-pathogenic agents

Area of Science:

• Biochemistry
• Immunology
• Microbiology

Background:

• Infectious diseases and pandemics pose a significant global health threat, exacerbated by increasing pathogen drug resistance and human-animal contact.
• Current pharmacological and medical advances struggle to keep pace with rapidly spreading infectious agents.
• There is a growing need for alternative therapies targeting microbial virulence and immune system regulation.

Purpose of the Study:

• To review the current research on itaconate metabolism across bacteria, fungi, and mammals.
• To comprehensively examine itaconate and its derivatives as potential anti-inflammatory, immunoregulatory, antimicrobial, and antiviral agents.
• To highlight challenges and future research directions for itaconate-based anti-pathogenic therapies.

Main Methods:

• Literature review of existing research on itaconate metabolism.
• Analysis of studies investigating the anti-inflammatory, immunomodulatory, antimicrobial, and antiviral properties of itaconate and its derivatives.
• Exploration of the mechanisms of action for these compounds.

Main Results:

• Itaconate and its derivatives exhibit diverse biological activities, including anti-inflammatory, immunomodulatory, antimicrobial, and antiviral effects.
• Research indicates established pathways for itaconate metabolism in various organisms.
• The mechanisms underlying the anti-pathogenic actions of itaconate derivatives are being elucidated.

Conclusions:

• Itaconate and its derivatives represent a promising class of compounds for developing novel anti-pathogenic strategies.
• Further research into their metabolism and mechanisms of action is crucial for clinical application.
• Overcoming existing challenges will pave the way for effective itaconate-based therapies against infectious diseases.